UK: Cadbury tables $4bn bid for Pfizer's Adams
UK confectionery and soft drinks giant Cadbury Schweppes, has tabled a US$4bn bid for Adams, the US chewing gum and functional foods company put on the market by the Pfizer pharmaceuticals group. Cadbury was very much in the running to buy Hershey Foods in the summer, and when that auction was called off, speculation immediately turned to Adams, the other likely acquisition candidate for the big names in the food industry. Adams makes Halls cough lozenges, as well as the popular Trident and Dentyne chewing gum brands.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 17 years of archives.
I am so confident you will love complete access to our content that today I can offer you 30 days access for $1.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- Why personalisation will take-off in US food
- General Mills sales woes continue - analysis
- US food next wave on display at Winter Fancy Food
- Comment: Meal kits in US - don't believe the hype
- Column: Kraft Heinz, Unilever and sustainability
- Unilever 'lining up spreads sale'
- UK own-label firm Park Cakes sold in MBO
- Immigration crackdown "risk" for US dairy industry
- BRF plant suspended amid bribery allegations
- Fonterra cuts earnings forecast